| Net Cash Provided by (Used in) Operating Activities |
$1,440,000 |
USD |
64% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,110,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
125,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
13,540,000 |
shares |
19% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$330,000 |
USD |
92% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$308,000 |
USD |
-83% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$23,000 |
USD |
360% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$177,533,000 |
USD |
1.7% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$177,582,000 |
USD |
1.6% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$81,000 |
USD |
-92% |
Q2 2024 |
Q2 2024 |
| Operating Lease, Liability, Current |
$0 |
USD |
-100% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$81,000 |
USD |
-83% |
Q2 2024 |
Q2 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0 |
pure |
-100% |
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$0 |
USD |
-100% |
Q2 2024 |
Q2 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$148,105,000 |
USD |
2% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$1,077,000 |
USD |
7.7% |
Q4 2024 |
FY 2024 |
| Operating Lease, Payments |
$81,000 |
USD |
-111% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$171,125,000 |
USD |
0.89% |
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
$0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$49,000 |
USD |
-57% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$1,004,000 |
USD |
-69% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$367,000 |
USD |
-86% |
Q2 2024 |
Q2 2024 |